TNDM Tandem Diabetes Care Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: TNDM

Price (delayed)

$20.77

Market cap

$1.35B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.47

Enterprise value

$1.64B

Tandem Diabetes Care is a public US medical device manufacturer based in San Diego, CA. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy. ...

Highlights
TNDM's revenue is up by 3.2% year-on-year
Tandem Diabetes Care's quick ratio has decreased by 35% YoY and by 2.8% from the previous quarter
The company's equity fell by 27% YoY and by 2.8% QoQ
Sector: Healthcare
Industry: Medical Devices
Website: https://www.tandemdiabetes.com/
Peers: DXCM ICUI PODD MDT

Key stats

What are the main financial stats of TNDM
Market
Shares outstanding
65.08M
Market cap
$1.35B
Enterprise value
$1.64B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
4.08
Price to sales (P/S)
1.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.08
Earnings
Revenue
$790.35M
EBIT
-$215.28M
EBITDA
-$200.47M
Free cash flow
-$30.43M
Per share
EPS
-$3.47
Free cash flow per share
-$0.47
Book value per share
$5.09
Revenue per share
$12.19
TBVPS
$14.6
Balance sheet
Total assets
$946.68M
Total liabilities
$617.44M
Debt
$420.29M
Equity
$329.23M
Working capital
$589.65M
Liquidity
Debt to equity
1.28
Current ratio
4.38
Quick ratio
3.47
Net debt/EBITDA
-1.44
Margins
EBITDA margin
-25.4%
Gross margin
51.2%
Net margin
-28.4%
Operating margin
-29.3%
Efficiency
Return on assets
-22.4%
Return on equity
-58.7%
Return on invested capital
-19.4%
Return on capital employed
-27.9%
Return on sales
-27.2%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

TNDM stock price

How has the Tandem Diabetes Care stock price performed over time
Intraday
-0.29%
1 week
0.87%
1 month
-24.39%
1 year
-58.25%
YTD
-53.79%
QTD
-15.36%

Financial performance

How have Tandem Diabetes Care's revenue and profit performed over time
Revenue
$790.35M
Gross profit
$404.59M
Operating income
-$231.9M
Net income
-$224.47M
Gross margin
51.2%
Net margin
-28.4%
The operating margin has contracted by 14% from the previous quarter
The operating income fell by 13% QoQ
The net margin has decreased by 11% from the previous quarter
The net income has decreased by 10% from the previous quarter

Growth

What is Tandem Diabetes Care's growth rate over time

Valuation

What is Tandem Diabetes Care stock price valuation
P/E
N/A
P/B
4.08
P/S
1.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.08
Tandem Diabetes Care's EPS has decreased by 10% from the previous quarter
TNDM's price to book (P/B) is 76% less than its 5-year quarterly average of 16.9 and 38% less than its last 4 quarters average of 6.6
The company's equity fell by 27% YoY and by 2.8% QoQ
The P/S is 83% lower than the 5-year quarterly average of 10.0 and 47% lower than the last 4 quarters average of 3.2
TNDM's revenue is up by 3.2% year-on-year

Efficiency

How efficient is Tandem Diabetes Care business performance
TNDM's ROE is down by 19% from the previous quarter
The return on invested capital has declined by 15% since the previous quarter
The return on assets has declined by 13% since the previous quarter
Tandem Diabetes Care's ROS has decreased by 11% from the previous quarter

Dividends

What is TNDM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TNDM.

Financial health

How did Tandem Diabetes Care financials performed over time
The total assets is 53% greater than the total liabilities
Tandem Diabetes Care's quick ratio has decreased by 35% YoY and by 2.8% from the previous quarter
TNDM's current ratio is down by 27% year-on-year
The debt is 28% more than the equity
The company's debt to equity rose by 36% YoY and by 3.2% QoQ
The company's equity fell by 27% YoY and by 2.8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.